Abstract:
Lung cancer is the leading cause of cancer death. Gene expression profiling of lung cancer may provide one method to increase our understanding of this very heterogeneous disease and potentially identify new approaches for early diagnosis, prognosis or treatment. This brief review examines some of the issues that are associated with the clinical presentation of this disease and some important questions that might be addressed using gene expression profiling experiments when applied to human lung cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
1.6 References
American Joint Commission for Cancer. 1998, AJCC Cancer Staging Handbook. 5th ed. Philadelphia, PA: Lippincott-Raven.
Beer, D.G., Kardia, S.L.R, Huang, C.C., Misek, D.E., Lin, L., Chen, G., Gharib, T.G., Giordano, T.J., Thomas, D.G., Lizyness, M.L., Kuick, R., Taylor, J.M.G., Iannettonni, M.D., Orringer, M.B., Hanash, S., 2002, Gene expression profiles define a high-risk group among stage I lung adenocarcinomas. Nat Med. 8:816–824.
Bhattacharjee, A., Richards, W.G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Behesti, J., Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E.J., Lander, E.S., Wong, W., Johnson, B.E., Golub, T.R., Sugarbaker, D.J., Meyerson, M., 2001, Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci. (USA) 98:13790–13795.
Borczuk, A.C., Gorenstein, L., Walter, K.L., Assaad, A.A., Wang, L., Powell, C.A., 2003 Non-small cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol. 163:1949–1960.
Brambilla, E., Travis, W.D., Colby, R.V., Corrin, B., Shimosato, Y., 2001, The new World Health Organization classifiction of lung tumours. Eur Respir J. 18(6): 1059–1068.
Brownson, R.C., Chang, J.C., Davis, J.R., 1992, Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiol. 3:61–64.
Bulzebruck, H., Bopp, R., Drings, P., Bauer, E., Krysa, S., Probst, G., van Kaick, G., Muller, K.M., Vogt-Moykopf, I., 1992, New aspects in the staging of lung cancer: prospective validation of the International Union Against Cancer TNM classification. Cancer 70:1102–1110.
Calderon, C., Kwembe, T., 1991, Modeling tumor growth. Math Biosci. 103(1):97–114.
Difilippantonio, S., Chen, Y., Pieta, A., Schluns, K., Pacyna-Gengelbach, M., Deutschmann, N., Padillla-Nash, H.M., Ried, T., Peterson, I., 2003, Gene expression profiles in human non-small and small cell lung cancers. Eur J Oncol. 39: 1936–1947.
Ferlay, J., Bray, F., Pisani, P., Parkin, D.M., 2001, Globocan 2000: Cancer Incidence, Mortality and Prevalence. Lyon, IARC Press.
Garber, M.E., Troyanskaya, O.G., Schleens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G.D., Perou, C.M., Whyte, R.I., Altman, R.B., Brown, P.O., Botstein D, Petersen, I., 2001, Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci. (USA) 98:13784–13789.
Geddes, D.M., 1979, The natural history of lung cancer: a review based on rates of tumor growth. Br J Dis Chest 73:1–17.
Heighway, J., Knapp, T., Boyce, L,, Brennand, S., Field, J.K., Betticher, D.C., Ratschiller, D., Gugger, M., Donovan, M., Lasek, A., Pickeert, P., 2002, Expression profiling of primary non-small lung cancer for target identification. Oncogene 21:7749–7763.
Jemal, A., Murray, T., Samuels, A., Ghaffor, A., Ward, E., Thun, M.J., 2003, Cancer statistics, 2003. CA Cancer J Clin. 53:5–26.
Kikuchi, T., Daigo, Y., Katagiri, T., Tsunoda, T., Okada, K., Kakiuchi, S., Zembutsu, H., Furukawa, Y., Kawamura, M., Koichi, K., Imai, K., Nakamura, Y., 2003, Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22:2192–2205.
Lubin, J.H., Blot, W.J., Berrino, F., Flamant, R., Gillis, C.R., Kunze, M., Schmahl, D., Visco,G., 1984, Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer 33:569–576.
Luk, C., Tsao, M.S., Bayania, J., Sheppard, F., Squire, J.A., 2001, Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization Cancer Genet Cytogenet. 125:87–99.
McDoniels-Silvers, A.L., Nimri, C.F., Stoner, G.D., Lubet, R.A., You, M., 2002. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res. 8:1127–1138.
Miuri, K., Bowman, E.D., Simon, R., Peng, A.C., Robles, A.I., Jones, R.T., Katagiri, T., He, P., Mizukami, H., Charboneau, L., Kikucki, T., Liotta, L.A., Nakamura, Y., Harris, C.C., 2002, Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking–and prognosis-related molecular profiles. Cancer Res. 62:3244–3250.
Nacht, M., Dracheva, T., Gao, Y., Fujii, T., Chen, Y., Player, A., Akmaev, V., Cook, B., Dufault, M., Zhang, M., Zhang, W., Guo, M-Z., Curran, J., Han, S., Sidransky, D., Buetow, K., Madden, S.L., Jen, J., 2001, Molecular characteristics of non-small cell lung cancer. Proc Natl Acad Sci. (USA) 98:15203–15208.
Nakamura, H., Saji, H., Ogata, A., Hosaka, M., Hagiwara, M., Saijo, T., Kawasaki, N., Kato, H., 2003, cDNA microarray analysis of gene expression in pathologic stage IA non-small cell lung carcinomas. Cancer 97:2798–2805.
Naruke, T., 1993, Significance of lymph node metastasis in lung cancer. Semin Thorac Cardiovasc Surg. 5:210–218.
Norton, L., Simon, R., Bereton, H., Bodgen, A., 1976, Predicting the course of Gompertzian growth. Nature 264:542–545.
Notter, M., Schwegler, N., 1989, Incidence of metastases and their distribution pattern in bronchial carcinoma. Autopsy findings during 5 decades (1935 to 1984) Dtsch Med Wochenschr. 114(9):343–349.
Petersen, S., Heckert, C., Rudolf, J., Schlun, K., Tchernitsa, O.I., Schafer, R., Dietel, M., Petersen, I., 2000, Gene expression profiling of advanced lung cancer. Int J Cancer 86:512–517.
Rivera, M.P., Detterbeck, F.C., Loomis, D.P., 2001, Epidemiology and classification of lung cancer, In: Diagnosis and Treatment of Lung Cancer: An Evidence-based Guide for the Practicing Clinician, W.B. Saunder Co, Philadelphia PA, Chapter 3, pp: 25–44.
Ryberg, D., Hewer, A., Phillips, D.H., Haugen, A., 1994, Differential susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res. 54:5801–5803.
Travis, W.D., Travis, L.B., Devesa, S.S., 1995, Lung cancer. Cancer 75:191–202.
US Dept. of Health and Human Services, 1998, Cigarette smoking among high school students-11 states, 1991-1997. Morbid Mortal Weekly Rep. 48:686–692.
Wigle, D.A., Jurisica, I., Radulovich, N., Pintilie, M., Rossant, J., Liu, N., Lu, C., Woodgett, J., Seiden, I., Johnston, M., Keshavjee, S., Darling, G., Winton, T., Breitkreutz, B-J., Jorgenson, P., Tyers, M., Sheppard, F.A., Tsao, M.S., 2002, Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res. 62:3005–3008.
Wikman, H., Kettunen, E., Seppanen, J.K., Karajainen, A., Hollmen, J., Anttila, S., Knuutila, S., 2002, Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21:5804–5813.
Wynder, E.L., Kabat, G.C., 1988, The effect of low tar cigarette smoking on lung cancer risk. Cancer 62:1223–1230.
Yamagata, N., Shyr, Y., Yanagisawa, K., Edgerton, M., Dang, T.P., Gonzalez, A., Nadaf, S., Larsen, P., Roberts, J.R., Nesbitt, J.C., Jensen, R., Levy, S., Moore, J.H., Minna, J.D., Carbone, D.P., 2003, A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res. 9:4695–4704.
Zheng, T., Holford, T.R., Boyle, P., Chen, Y., Ward, B.A., Flannery, J., Mayne, S.T., 1994, Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989. Cancer 74:1556–1567.
Zang, E.A., Wynder, E.L., 1996, Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 88:183–192.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc. Boston
About this chapter
Cite this chapter
Beer, D.G. (2005). Cancer: Clinical Challenges and Opportunities. In: Shoemaker, J.S., Lin, S.M. (eds) Methods of Microarray Data Analysis. Springer, Boston, MA. https://doi.org/10.1007/0-387-23077-7_2
Download citation
DOI: https://doi.org/10.1007/0-387-23077-7_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23074-0
Online ISBN: 978-0-387-23077-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)